These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors. Bessell EM, Graus F, Lopez-Guillermo A, Lewis SA, Villa S, Verger E, Petit J. Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):501-8. PubMed ID: 15145169 [Abstract] [Full Text] [Related]
10. [High dose methotrexate with leucovorin rescue in the treatment of malignant lymphoma]. Sampi K, Hattori M. Gan To Kagaku Ryoho; 1982 Jul 01; 9(6):1068-73. PubMed ID: 6985194 [Abstract] [Full Text] [Related]
11. [Provisional treatment results of intensive combination chemotherapy (m-BACOD) in non-Hodgkin lymphoma of intermediate and high malignancy]. Knecht H, Streuli RA, Odermatt BF, Rhyner K. Schweiz Med Wochenschr; 1987 Dec 12; 117(50):2038-41. PubMed ID: 2448874 [Abstract] [Full Text] [Related]
12. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL). Gobbi PG, Ghirardelli ML, Avanzini P, Baldini L, Quarta G, Stelitano C, Broglia C, Loni C, Silingardi V, Ascari E. Haematologica; 2000 Mar 12; 85(3):263-8. PubMed ID: 10702814 [Abstract] [Full Text] [Related]
17. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study. Lange BJ, Blatt J, Sather HN, Meadows AT. Med Pediatr Oncol; 1996 Jul 01; 27(1):15-20. PubMed ID: 8614385 [Abstract] [Full Text] [Related]